{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:54:53Z","timestamp":1782118493063,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1053\/j.gastro.2009.05.015","type":"journal-article","created":{"date-parts":[[2009,5,30]],"date-time":"2009-05-30T04:24:21Z","timestamp":1243657461000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat"],"prefix":"10.1053","volume":"137","author":[{"given":"Kenneth E.L.","family":"McColl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.05.015_bib1","series-title":"Medicinal product statistics in Denmark 2007","year":"2008"},{"key":"10.1053\/j.gastro.2009.05.015_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Over-prescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2009.05.015_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","article-title":"Proton pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy","volume":"137","author":"Reimer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.05.015_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.44.4.468","article-title":"Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole","volume":"44","author":"Gillen","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.05.015_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.05.015_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0016-5085(86)90938-8","article-title":"Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation studies with omeprazole and ranitidine in intact and antrectomized rats","volume":"90","author":"Larsson","year":"1986","journal-title":"Gastroenterology"},{"issue":"Suppl 118","key":"10.1053\/j.gastro.2009.05.015_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/00365528609090884","article-title":"Pharmacology and toxicology of omeprazole\u2014with special reference to the effects on gastric mucosa","volume":"21","author":"Carlsson","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.05.015_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.39.5.649","article-title":"Marked increase in gastric acid secretory capacity after omeprazole treatment","volume":"39","author":"Waldum","year":"1996","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.05.015_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(99)70118-6","article-title":"Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status","volume":"116","author":"Gillen","year":"1999","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.gastro.2009.05.015_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2004.01.004","article-title":"Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment","volume":"126","author":"Gillen","year":"2004","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2009.05.015_bib11","first-page":"797","article-title":"Dyspeptic symptoms development after discontinuation of a proton pump inhibitor: clinical importance of acid-rebound","volume":"134","author":"Niklasson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.05.015_bib12","series-title":"NICE Clinical Guideline 17","year":"2004"},{"key":"10.1053\/j.gastro.2009.05.015_bib13","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Guidelines for the management of dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.05.015_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomised, placebo-controlled trials (the Bond and Opera studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2009.05.015_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/gut.30.4.449","article-title":"Rebound nocturnal hypersecretion after four weeks treatment with an H2-receptor antagonist","volume":"30","author":"Fullarton","year":"1989","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2009.05.015_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2036.1991.tb00042.x","article-title":"Rebound hypersecretion after H2-antagonist withdrawal\u2014a comparative study with nizatidine, ranitidine and famotidine","volume":"5","author":"Fullarton","year":"1991","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2009.05.015_bib17","first-page":"1209","article-title":"dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers","volume":"94","author":"Smith","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.05.015_bib18","first-page":"245","article-title":"CCKB\/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders","volume":"69","author":"Jensen","year":"1996","journal-title":"Yale J Biol Med"},{"key":"10.1053\/j.gastro.2009.05.015_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/clpt.1993.185","article-title":"The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans","volume":"54","author":"Murphy","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2009.05.015_bib20","first-page":"G699","article-title":"Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression","volume":"269","author":"Nishida","year":"1995","journal-title":"Am J Physiol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850900780X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850900780X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:49:27Z","timestamp":1758034167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650850900780X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S001650850900780X"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.05.015","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.03.058","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}